Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Combination Chemotherapy with Actinomycin D and Ribonuclease : an Example of Complementary Inhibition

Nature volume 203, pages 877–878 (1964)Cite this article

Abstract

Two mechanisms have been suggested by which combinations of drugs may depress the intracellular availability of a given metabolite to a level that becomes limiting for cell survival. Potter1 has applied the term sequential inhibition to the action of two or more inhibitors on different enzymes in a limited portion of a multi-enzyme sequence (equation 1), and Elion, Singer and Hitchings2 have denoted as concurrent blockade the simultaneous retardation, by two or more agents, of alternate biochemical routes to the same end-product (equation 2).

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Potter, V. R. Proc. Soc. Exp. Biol. Med., 76, 41 (1951).

    Article  CAS  Google Scholar 

  2. Elion, G. B., Singer, S., and Hitchings, G. H., J. Biol. Chem., 208, 477 (1954).

    CAS  PubMed  Google Scholar 

  3. Karnofsky, D. A., and Clarkson, B. D., Ann. Rev. Pharmacol., 3, 357 (1963).

    Article  Google Scholar 

  4. Brockman, R. W., and Anderson, E. P., Ann. Rev. Biochem., 32, 463 (1963).

    Article  CAS  Google Scholar 

  5. Bergel, F., Chemistry of Enzymes in Cancer (Charles C. Thomas, Springfield, Illinois, 1961).

    Google Scholar 

  6. Sartorelli, A. C., Bieber, A. L., Chang, P. K., and Fischer, G. A., Biochem. Pharmacol., 13, 507 (1964).

    Article  CAS  Google Scholar 

  7. Booth, B. A., and Sartorelli, A. C., Science, 138, 518 (1962).

    Article  ADS  CAS  Google Scholar 

  8. Booth, B. A., and Sartorelli, A. C., Cancer Res., 23, 1762 (1963).

    CAS  PubMed  Google Scholar 

  9. Sartorelli, A. C., and Booth, A. C., Proc. Amer. Assoc. Cancer Res., 5, 32 (1964).

    Google Scholar 

  10. Schneider, W. C., in Methods in Enzymology, edit. by Colowick, S. P., and Kaplan, N. O., 3, 680 (Academic Press Inc., New York, 1957).

    Book  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacology, Yale University School of Medicine, New Haven, Conn.

    ALAN C. SARTORELLI

Authors
  1. ALAN C. SARTORELLI
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

SARTORELLI, A. Combination Chemotherapy with Actinomycin D and Ribonuclease : an Example of Complementary Inhibition. Nature 203, 877–878 (1964). https://doi.org/10.1038/203877a0

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/203877a0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing